Re-Treatment with EGFR-TKIs in NSCLC Patients Who Developed Acquired Resistance

by Wen-Shuo Wu, Yuh-Min Chen
Published 2014-06-01

Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis

by Gerd Burmester, Josef S Smolen, Masayoshi Harigai, Kevin Winthrop, Yi-Ming Chen, Tsu-Yi Hsieh, Chad Walls, Wen-Shuo Wu, Christina Dickson, Ran Liao
Published 2020-05-01

HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs?

by Gerd Burmester, Josef S Smolen, Masayoshi Harigai, Kevin Winthrop, Yi-Ming Chen, Tsu-Yi Hsieh, Chad Walls, Wen-Shuo Wu, Christina Dickson, Ran Liao
Published 2020-05-01

Estimating the response and economic burden of rheumatoid arthritis patients treated with biologic disease-modifying antirheumatic drugs in Taiwan using the National Health Insuran...

by Qiang Shi, Ko-Jen Li, Tamas Treuer, Bruce C M Wang, Carol L Gaich, Chien-Hsun Lee, Wen-Shuo Wu, Wesley Furnback, Chao-Hsiun Tang
Published 2018-01-01